Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

Popular global HIV/AIDS program PEPFAR has been spared as Congress passes a package with billions of dollars in spending cuts ...

The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to ...

This groundbreaking HIV initiative designed to meet Black and LGBTQ+ communities where they are — spiritually, culturally, ...

A San Francisco firefighter who contracted HIV on the job while heroically treating an injured patient is being denied his ...

HIV care and its related outcomes in South Carolina were defined by racial disparities, specifically in retention in care, ...

For many Jamaicans, memories of HIV/AIDS as a virtual death sentence, dating back to the 1980s and 90s, remain strong. To ...

The Bahamas recorded 156 cases of HIV infections last year, as health officials revealed that there were nearly 4,000 people ...

A BREAKTHROUGH HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

Six months after President Donald Trump's foreign aid cuts, millions have lost access to HIV prevention medication.

A major HIV drug maker will return $202 million nationwide after a multi-year investigation and settlement. Pharmaceutical ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...